Team:ETH Zurich/Modeling/Overview
From 2008.igem.org
Luca.Gerosa (Talk | contribs) |
Luca.Gerosa (Talk | contribs) |
||
Line 50: | Line 50: | ||
The state-of-the-art genome scale model for E.Coli iAF1260 (1260 genes included) has been modified in order to account for thymidine auxotrophycity, thymidine uptaking limitation, genome reduction and growth on different medium. Flux balance analysis has been applied to determine growth rates.<br><br> | The state-of-the-art genome scale model for E.Coli iAF1260 (1260 genes included) has been modified in order to account for thymidine auxotrophycity, thymidine uptaking limitation, genome reduction and growth on different medium. Flux balance analysis has been applied to determine growth rates.<br><br> | ||
'''Results:''' <br> | '''Results:''' <br> | ||
- | + | It is indeed possible to select reduced genome strains using thymidine limitation. The quantification shows that the method is at the border line with the sensitivity of chemostat machinery setup. Predictions shows the possibility of reducing 4% of genes for a minimal medium growing strains and 8% of genese for rich medium growing strains. | |
<br><br> | <br><br> | ||
</div> | </div> |
Revision as of 16:10, 11 October 2008
Overview on the modelling frameworkThis page is meant to give an introduction to the the overall modelling framework we have constructed in order to asses feasibility analysis, temporal scale details and other parameter estimations that regard our project setup. As introduced in the project overview section, four main components can be identified in the deviced mechanism. Accordingly, we divided the modelling framework in four modules that tackles the relative problematics.
|